These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 30569513
1. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival. Feng H, Zhang J, Shi Y, Wang L, Zhang C, Wu L. J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513 [Abstract] [Full Text] [Related]
2. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21. Liu W. Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482 [Abstract] [Full Text] [Related]
3. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T, Huang S, Han F. Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404 [Abstract] [Full Text] [Related]
6. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis. Yuan Z, Xiu C, Liu D, Zhou G, Yang H, Pei R, Ding C, Cui X, Sun J, Song K. J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448 [Abstract] [Full Text] [Related]
7. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p]. Yang H, Cao C, Wang LJ. Zhonghua Zhong Liu Za Zhi; 2020 Apr 23; 42(4):325-330. PubMed ID: 32375449 [Abstract] [Full Text] [Related]
8. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer. Zhang L, Chen J, Wang L, Chen L, Du Z, Zhu L, Cui M, Zhang M, Song L. J Cell Biochem; 2019 Dec 23; 120(12):19345-19357. PubMed ID: 31464068 [Abstract] [Full Text] [Related]
9. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN. Wang S, Jiang W, Zhang X, Lu Z, Geng Q, Wang W, Li N, Cai X. Cancer Med; 2020 Mar 23; 9(6):1999-2009. PubMed ID: 31981466 [Abstract] [Full Text] [Related]
10. LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p. Li D, Hu A. Am J Med Sci; 2024 Mar 23; 367(3):201-211. PubMed ID: 37660994 [Abstract] [Full Text] [Related]
12. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21. Rong H, Chen B, Ma K, Wei X, Peng J, Zhu J. Cancer Biother Radiopharm; 2021 Apr 23; 36(3):273-279. PubMed ID: 32401035 [Abstract] [Full Text] [Related]
14. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis. Chi J, Liu T, Shi C, Luo H, Wu Z, Xiong B, Liu S, Zeng Y. Biomed Pharmacother; 2019 Oct 23; 118():109201. PubMed ID: 31545227 [Abstract] [Full Text] [Related]
15. LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint. Hong L, Wang H, Wang J, Wei S, Zhang F, Han J, Liu Y, Ma M, Liu C, Xu Y, Jiang D. Cancer Manag Res; 2019 Oct 23; 11():10393-10399. PubMed ID: 31849528 [Abstract] [Full Text] [Related]
16. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1. Yang X, Miao S, Mao X, Xiu C, Sun J, Pei R, Jia S. Pathol Oncol Res; 2021 Oct 23; 27():584466. PubMed ID: 34257531 [Abstract] [Full Text] [Related]
17. Role of Long Non-Coding RNA (LncRNA) LINC-PINT Downregulation in Cardiomyopathy and Retinopathy Progression Among Patients with Type 2 Diabetes. Zha T, Su F, Liu X, Yang C, Liu L. Med Sci Monit; 2019 Nov 11; 25():8509-8514. PubMed ID: 31711064 [Abstract] [Full Text] [Related]
18. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer. Zhang Y, Yuan Y, Zhang Y, Cheng L, Zhou X, Chen K. Cell Cycle; 2020 Jan 11; 19(1):142-152. PubMed ID: 31814518 [Abstract] [Full Text] [Related]
19. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression. Jia M, Li Z, Pan M, Tao M, Wang J, Lu X. Mol Ther Nucleic Acids; 2020 Dec 04; 22():319-328. PubMed ID: 33230437 [Abstract] [Full Text] [Related]
20. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2. Zhou Q, Guo J, Huang W, Yu X, Xu C, Long X. Mol Oncol; 2020 Sep 04; 14(9):2231-2250. PubMed ID: 32335998 [Abstract] [Full Text] [Related] Page: [Next] [New Search]